August 2020

A full case study from our August 2020 issue.

Although overall incidence rate has declined slightly in recent years, increases in the incidence in certain subgroups emphasize the importance of early diagnosis, risk-based screening, and PrEP for at-risk individuals.

Evidence is accumulating that influenza vaccination protection wanes over the course of a single influenza season, with significant implications for public health.

Intravenous (IV) fosfomycin offers a novel therapeutic option in the treatment of systemic multi-drug resistant (MDR) infections. Unanswered questions remain regarding its efficacy and specific role in our therapeutic arsenal.

In this narrative review of studies evaluating antiretroviral stewardship programs (ARVSPs), we propose core elements for ARVSPs that are based on published evidence, clinical experience, and adapted from antimicrobial stewardship programs.

We review current and emerging treatment options for infections caused by the difficult-to-treat, intrinsically multidrug-resistant organism Stenotrophomonas maltophilia.

Use of an IL-6 inhibitor has the potential to prevent the cytokine storm caused by severe COVID-19 infection.

Clinically, C kroppenstedtii has been isolated largely from female subjects, with most samples resulting from breast tissue and the remainder identified in blood, sputum, lung, and prosthetic valve infections.